Personal Investment Vitae

Home > Personal Investment Vitae

AYA Personal Investment Vitae as of February 2026
Daisy Harvey @Daisy Harvey
Platinum member since January 2017

Location: United States

Gender: Female

Asset investment style: Quantitative fundamental analysis

Market capitalization:

$8,090,223talents

Virtual portfolio value:

$5,124,524talents

Net overall return per annum:

19.63%

AYA current rank order:

#13

Asset investment philosophy:
Daisy Harvey trades U.S. stocks with the top #76 to #500 positive alpha signals.

Top 10 profitable stock transactions since January 2020Strategy

Symbol Company Buy Sell Share Volume Return (%) Profit ($)
VATE INNOVATE Corp. Common Stock $0.53 $4.14 56,283 +681.13% $203,182
RMBL RumbleOn Inc. Class B Common Stock $0.36 $7.95 24,133 +2,108.33% $183,169
LGVN Longeveron Inc. Class A Common Stock $3.45 $26.25 2,347 +660.87% $53,512
AXSM Axsome Therapeutics Inc. Common Stock $4.60 $31.75 1,335 +590.22% $36,245
LSCC Lattice Semiconductor Corporation Common Stock $6.97 $48.04 881 +589.24% $36,183
SQ Block Inc. Class A Common Stock $14.50 $99.54 423 +586.48% $35,972
FIVN Five9 Inc. Common Stock $16.31 $110.10 376 +575.05% $35,265
TRNS Transcat Inc. Common Stock $11.35 $73.00 541 +543.17% $33,353
GLOB Globant S.A. Common Shares $34.57 $215.99 177 +524.79% $32,111
HZNP Horizon Therapeutics Public Limited Company Ordinary Shares $16.41 $98.56 374 +500.61% $30,724
Sum $679,716

Top 10 current stock portfolio positions as of February 2026Strategy

Top 20 influencers

#1 - #5 #6 - #10 #11 - #15 #15 - #20
@Chanel Holden
@Andy Yeh Alpha

Blog+More

Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties.

Rose Prince

2018-10-15 09:33:00 Monday ET

Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties.

Several pharmaceutical companies now switch their primary focus from generic prescription drugs to medical specialties such as cardiovascular medications an

+See More

Bank leverage and capital bias adjustment through the macroeconomic cycle

Fiona Sydney

2023-12-04 12:30:00 Monday ET

Bank leverage and capital bias adjustment through the macroeconomic cycle

Bank leverage and capital bias adjustment through the macroeconomic cycle   Abstract We assess the quantitative effects of the recent proposal

+See More

CEO overconfidence and corporate performance

Laura Hermes

2022-11-05 11:32:00 Saturday ET

CEO overconfidence and corporate performance

CEO overconfidence and corporate performance Malmendier and Tate (JFE 2008, JF 2005) argue that overconfident CEOs are more likely to initiate mergers an

+See More

New Keynesian monetary policy framework

Monica McNeil

2023-09-21 09:26:00 Thursday ET

New Keynesian monetary policy framework

Jordi Gali delves into the science of the New Keynesian monetary policy framework with economic output and inflation stabilization. Jordi Gali (2015)

+See More

There are several highlights from the first news conference after Trump's presidential election victory.

Monica McNeil

2017-01-23 09:30:00 Monday ET

There are several highlights from the first news conference after Trump's presidential election victory.

There are several highlights from the first news conference after Trump's presidential election victory: The Trump administration will repeal-and-

+See More

What are the mainstream legal origins of President Trump's new tariff policies?

Amy Hamilton

2025-06-13 08:23:00 Friday ET

What are the mainstream legal origins of President Trump's new tariff policies?

What are the mainstream legal origins of President Trump’s new tariff policies? We delve into the mainstream legal origins of President Trump&rsquo

+See More